4//SEC Filing
Nolan Lisa 4
Accession 0001140361-18-011675
CIK 0001228627other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:44 PM ET
Size
6.7 KB
Accession
0001140361-18-011675
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2018-02-28+1,625→ 1,625 total - Exercise/Conversion
Restricted Stock Units
2018-02-28+1,625→ 4,875 total→ Common Stock (1,625 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F2]On January 20, 2017, the reporting person was granted 6,500 RSUs, of which 1,625 vested on February 28, 2018. The remaining RSUs will vest in three equal annual installments on the last business day in February, beginning February 28, 2019.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001661400
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:44 PM ET
- Size
- 6.7 KB